Study of immune response to yellow fever vaccine
Part of Infections clinical trials.
This study looks at how your body's immune system responds to the yellow fever vaccine. It may help researchers understand how well the vaccine protects people.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You need the yellow fever vaccine (and possibly the typhoid vaccine)
- You can come for two appointments, one week apart
- You can have a blood sample taken (about 3 tablespoons total)
- You have not had a yellow fever or typhoid vaccine before
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers safety and antibody information from women who received their first yellow fever vaccine either during pregnancy or outside of pregnancy. It aims to better understand how the vaccine affects pregnant women and their babies.
This study looks at how your body's cells respond after getting a hepatitis B vaccine. It may help researchers understand how well the vaccine works.
This study looks at how your immune system “remembers” the yellow fever vaccine over time. It may help researchers understand long-term immune protection and how it varies between people.
This study examines special immune cells that live in your skin to understand how they work. Researchers will take small skin samples to learn more about your body's natural defenses, which could help develop better vaccines in the future.
This trial studies how well the yellow fever vaccine “17D” stimulates the immune system (the body’s germ-fighting response) in adults who were vaccinated with 17D years ago. It may help researchers understand whether a prior vaccination still provides protection and how strong the immune response is.
This trial tests a new yellow fever vaccine in young children. It will see if the vaccine is safe and produces a good immune response, including when given with the MMR vaccine.
Hear when a new Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.